id
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-03-09 23:47:26
expired found date
-
created at
2024-06-04 22:12:58
updated at
2025-12-28 02:30:52
length
16
crc
54744
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
184223
mp size raw text
797
mp inner links count
1
mp inner links status
20 (imported)
title
Matchpoint Therapeutics
description
Matchpoint aims to discover and develop precision small molecules that harness the power of covalency to bring new possibilities to the treatment of serious immune disease and cancer.
site name
Matchpoint Therapeutics
author
updated
2025-12-15 16:59:29
raw text
Matchpoint Therapeutics Skip to main content Science Approach Leadership Careers Acing the future of covalent medicines. Matchpoint is discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases. Scroll The power of covalency The irreversible bond formed between a covalent medicine and its protein target imparts unique pharmacological benefits and greatly expands the number of disease-causing proteins that can be therapeutically targeted. Expanding the druggable proteome Deployment of covalent molecules during chemoproteomics screening enables detection of allosteric, transient, and cryptic binding pockets that would otherwise be missed with traditional, high throughput screening methods.
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
2025110801
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
658
text words
101
text unique words
76
text lines
16
text sentences
4
text paragraphs
2
text words per sentence
25
text matched phrases
3
text matched dictionaries
3
links self subdomains
0
links other subdomains
links other domains
4 - timmermanreport.com, biospace.com, bizjournals.com, biocentury.com
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
2 - linkedin.com, twitter.com
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-15 16:59:29
rss path
rss status
32 (unknown)
rss found date
2024-03-13 00:57:38
rss size orig
16342
rss items
5
rss spam phrases
0
rss detected language
1 (English)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)
sitemap review version
2
sitemap urls count
8
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-03-12 16:15:41
sitemap process date
2025-03-08 05:56:50
sitemap first import date
-
sitemap last import date
2025-04-02 10:56:46